Navigation Links
OPPI Opposes Draft National Pharmaceuticals Policy

Coming down heavily on the draft National Pharmaceuticals Policy, industry body OPPI has said the proposed policy will hamper the growth of the pharmaceutical sector // and lead to the destruction of Indian pharma companies.

"The previous governments had reduced the number of drugs under control from 347 to 143 and finally to 74. The Drug Policy in February 2002 had proposed a further reduction from 74 to about 30. The current policy hence will not promote the industry but would hamper its growth," Director General of Organisation of Pharmaceutical Producers of India Ajit V Dangi told PTI.

"The move (of bringing more drugs under price control) will act as a barrier to our growing markets and it will lead to the destruction of Indian Pharma companies," he said.

Instead of widening the list of drugs under the price control regime, the government should ensure access to basic healthcare facilities, Dangi added.

Criticising the proposal to include 354 drugs in the price control regime, he said it would drastically hit the margins of drug manufacturers.

He said the prices of medicines were already lowest in India, even lower than other neighbouring countries like Bangladesh, Sri lanka and Indonesia and there were no apparent reasons to reduce them further.

If the government wanted to lower it further then it should be looking at drugs taxation, he observed. The easier way to reduce prices is to cut taxes such as excise duty which push the prices of medicines up by 75 percent.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. HIV Patients Opposes Patenting Of AIDS Drug
2. Goa Christian Council Opposes Mandatory HIV Test
3. Smoking Ban Draft Is Put For Consultation
4. Kerala Drafts a New Health Tourism Policy
5. National Lung Study in the process
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Hepatitis B Vaccine To Be Included In National Immunization Programme
8. UK Govt Says On Course For National Chlamydia Screening
9. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
10. India extends National TB Control Program
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... , ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of ... is the creation of published author, Jeanine Liston, a busy mother of five who used ... “I have been writing this book for over twenty years. It was a way ...
(Date:9/19/2017)... Houston, Texas (PRWEB) , ... September 19, 2017 ... ... Win Promotions and the Brazilian jiu-jitsu community have raised more than $15,000 in ... to the mats in professional submission grappling matches and world-class instructor seminars, organizers ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Trusted debt-reduction firm ... 175,000 debt accounts, translating to in excess of $835 million in resolved debt for ... other unsecured loans are some of the categories of debt settled by the company. ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... Society of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” with an ... Members as it focused on best practices for third party administrators (TPAs) related ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent ... as the number one company for hearing aids, ranking it ... fifteen other brands. ... Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... -- NuvoAir (formerly called Pond Healthcare Innovation), the ... with Novartis Pharma AG to distribute NuvoAir,s spirometry technology to ... mobile spirometry platform and Novartis, commitment to address the unmet ... ... ...
Breaking Medicine Technology: